Access cutting-edge autism spectrum disorder treatment through this clinical trial at a research site in East Lansing. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this East Lansing location
Preparing your pre-screening questions…
Access autism spectrum disorder specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related autism spectrum disorder treatment provided free
Check if you qualify for this autism spectrum disorder clinical trial in East Lansing, MI
No-Cost Study Care
Local to East Lansing
Convenient for MI residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The long-term study goal is to experimentally evaluate the components (and likely active ingredients) of early language interventions for young children with ASD. The overall objective is to determine how single-word and telegraphic simplification affects real-time language processing and word learning in young children with ASD (relative to full, grammatical utterances). The proposed project will investigate three specific aims: 1) Determine how single-word and telegraphic simplification affects language processing. 2) Determine how single-word and telegraphic simplification affects word learning. 3) Evaluate child characteristics that may moderate the effects of linguistic simplification on language processing and word learning. Aim 1 will test the hypothesis that children with ASD will process full, grammatical utterances faster and more accurately than single-word or telegraphic utterances. Aim 2 will test the hypothesis that full, grammatical utterances will support word learning better than telegraphic or single-word utterances. Aim 3 will test the hypothesis that language and cognitive skills significantly moderate the effects of linguistic simplification on language processing and word learning in young children with ASD.
Sponsor: Michigan State University
Yes, this clinical trial (NCT05707923) has an active research site in East Lansing, MI that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for autism spectrum disorder treatment options in East Lansing, MI, this clinical trial (NCT05707923) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our East Lansing research site is actively enrolling participants for this clinical trial. You'll receive care from experienced autism spectrum disorder specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all autism spectrum disorder clinical trials near you to find additional studies recruiting in your area.
See all pulmonary embolism clinical trials recruiting in East Lansing — not just this study.
Browse Pulmonary Embolism Trials in East Lansing →